Hellenic Dynamics (HELD) Competitors GBX 0.0095 0.00 (0.00%) As of 05/19/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock HELD vs. CEL, N4P, HLN, BXP, HIK, HCM, INDV, AMYT, AGY, and APHShould you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include Celadon Pharmaceuticals (CEL), N4 Pharma (N4P), Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), and Alliance Pharma (APH). These companies are all part of the "drug manufacturers - specialty & generic" industry. Hellenic Dynamics vs. Celadon Pharmaceuticals N4 Pharma Haleon Beximco Pharmaceuticals Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Allergy Therapeutics Alliance Pharma Celadon Pharmaceuticals (LON:CEL) and Hellenic Dynamics (LON:HELD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk. Is CEL or HELD more profitable? Hellenic Dynamics has a net margin of 0.00% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Celadon Pharmaceuticals' return on equity of -187.26% beat Hellenic Dynamics' return on equity.Company Net Margins Return on Equity Return on Assets Celadon Pharmaceuticals-4,024.62% -187.26% -34.40% Hellenic Dynamics N/A -364.21%N/A Which has better valuation & earnings, CEL or HELD? Celadon Pharmaceuticals has higher revenue and earnings than Hellenic Dynamics. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than Hellenic Dynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeladon Pharmaceuticals£123.38K19.88-£4.97M-£7.98-0.50Hellenic DynamicsN/AN/A-£5.22M-£3.550.00 Do insiders & institutionals hold more shares of CEL or HELD? 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. Comparatively, 0.1% of Hellenic Dynamics shares are held by institutional investors. 65.1% of Celadon Pharmaceuticals shares are held by insiders. Comparatively, 72.9% of Hellenic Dynamics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community favor CEL or HELD? Celadon Pharmaceuticals received 4 more outperform votes than Hellenic Dynamics when rated by MarketBeat users. CompanyUnderperformOutperformCeladon PharmaceuticalsOutperform Votes4100.00% Underperform VotesNo VotesHellenic DynamicsN/AN/A Does the media favor CEL or HELD? In the previous week, Celadon Pharmaceuticals' average media sentiment score of 0.00 equaled Hellenic Dynamics'average media sentiment score. Company Overall Sentiment Celadon Pharmaceuticals Neutral Hellenic Dynamics Neutral SummaryCeladon Pharmaceuticals and Hellenic Dynamics tied by winning 5 of the 10 factors compared between the two stocks. Get Hellenic Dynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HELD vs. The Competition Export to ExcelMetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£14,000.00£2.17B£5.38B£2.66BDividend YieldN/A2.92%5.21%5.05%P/E Ratio0.003.9726.80134.04Price / SalesN/A552.76389.55215,627.72Price / CashN/A10.2538.2528.02Price / Book0.017.186.803.80Net Income-£5.22M£20.70B£3.23B£5.88B7 Day PerformanceN/A-0.35%1.53%0.50%1 Month PerformanceN/A4.91%10.05%21.94%1 Year PerformanceN/A89.90%16.75%119.00% Hellenic Dynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HELDHellenic DynamicsN/AGBX 0.01flatN/AN/A£14,000.00N/A0.00N/ACELCeladon PharmaceuticalsN/AGBX 5+11.1%N/A-95.0%£3.07M£123,381.65-0.632,780Gap UpN4PN4 PharmaN/AGBX 0.52+2.7%N/A-42.4%£2.26M£8,841.37-1.515Gap UpHLNHaleon2.0829 of 5 starsGBX 405.30+1.5%GBX 457+12.8%+24.8%£36.58B£11.07B34.0925,408News CoverageInsider TradeHigh Trading VolumeBXPBeximco PharmaceuticalsN/AGBX 34.75-3.5%N/A-12.5%£23.69B£7.08T3.735,500Gap DownHigh Trading VolumeHIKHikma Pharmaceuticals3.6744 of 5 starsGBX 2,022-0.1%GBX 2,655+31.3%+7.6%£5.61B£3.74B19.849,100HCMHUTCHMEDN/AGBX 218.30-1.2%N/A-32.4%£2.37B£771.01M-55.721,760News CoverageINDVIndivior1.6836 of 5 starsGBX 841-0.1%GBX 1,650+96.2%-36.2%£1.31B£1.40B-697.311,000AMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 7.25+0.7%N/A+105.9%£356.34M£72.18M-6.99612High Trading VolumeAPHAlliance Pharma1.8565 of 5 starsGBX 64.52-0.1%GBX 6,250+9,587.1%N/A£349.34M£183.50M-10.4091,000 Related Companies and Tools Related Companies Celadon Pharmaceuticals Competitors N4 Pharma Competitors Haleon Competitors Beximco Pharmaceuticals Competitors Hikma Pharmaceuticals Competitors HUTCHMED Competitors Indivior Competitors Amryt Pharma Competitors Allergy Therapeutics Competitors Alliance Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HELD) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hellenic Dynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hellenic Dynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HELD Stock Free HELD Stock Alerts